Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
29.14 32.36 37.64 41.40

+8 more quarters

P/S ratio
4.00 4.67 4.98 5.35
P/FCF ratio
23.88 25.68 27.53 31.36
P/Operating CF
72.04 95.75 216.55 62.68
P/B ratio
4.49 5.03 5.48 5.99
EV/Sales
4.45 5.12 5.44 5.82
EV/EBITDA
17.61 19.57 22.16 24.02
EV/FCF
26.52 28.12 30.10 34.11
Current Ratio
2.18 2.16 2.11 1.89
Net Debt/EBITDA
8.77 5.87 9.51 5.55
Debt/Equity
0.64 0.62 0.64 0.71
Earnings Yield
3.43% 3.09% 2.66% 2.42%
Free Cash Flow Yield
4.19% 3.89% 3.63% 3.19%
Free Cash Flow per Share
3.20 2.76 1.08 4.47
Book value per Share
61.37 62.55 60.01 58.66
Free Cash Flow
1,224.00 1,059.00 415.00 1,710.00
EV/EBIT
21.52 23.89 27.58 29.88
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026